Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
|
2
|
Resverlogix Corp.
|
May 30, 2017 03:34PM
|
Re: Resverlogix Corp. Selected to Present at Cavendish Global Health Impact Forum
|
4
|
Resverlogix Corp.
|
Oct 22, 2015 09:51AM
|
Re: Resverlogix Closes $10 Million of Equity Subscriptions
|
1
|
Resverlogix Corp.
|
Jun 20, 2017 09:51AM
|
Re: Resverlogix Closes $10 Million of Equity Subscriptions
|
2
|
Resverlogix Corp.
|
Jun 20, 2017 12:00PM
|
Re: Resverlogix Announces Proposed Offering of Units
|
3
|
Resverlogix Corp.
|
May 14, 2019 06:51PM
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 12:25PM
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
4
|
Resverlogix Corp.
|
Mar 12, 2019 11:28AM
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
7
|
Resverlogix Corp.
|
Mar 12, 2019 01:55PM
|
Re: Resverlogix Announces Participation at Leading, International Scientific Conferences
|
2
|
Resverlogix Corp.
|
Jun 10, 2019 10:15AM
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
2
|
Resverlogix Corp.
|
Sep 23, 2019 08:47AM
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
1
|
Resverlogix Corp.
|
Sep 23, 2019 09:04AM
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
1
|
Resverlogix Corp.
|
Sep 23, 2019 10:08AM
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
4
|
Resverlogix Corp.
|
Aug 23, 2019 09:09AM
|
Re: Primary outcome HR= .82 (18% RRR) P=0.11
|
1
|
Resverlogix Corp.
|
Nov 16, 2019 12:06PM
|
Re: Price action
|
2
|
Resverlogix Corp.
|
Sep 27, 2016 11:56AM
|
Re: Price action
|
5
|
Resverlogix Corp.
|
Sep 27, 2016 01:47PM
|
Re: Price action
|
1
|
Resverlogix Corp.
|
Sep 27, 2016 02:11PM
|
Re: price
|
3
|
Resverlogix Corp.
|
Jan 26, 2016 04:02PM
|
Re: POTENTIAL.
|
3
|
Resverlogix Corp.
|
Nov 12, 2015 07:31PM
|
Re: PNH
|
1
|
Resverlogix Corp.
|
Sep 24, 2015 09:09PM
|